Abstract
Alibrary of novel spiro[pyrazole-4,5′-isoxazoline]-5-one derivatives were designed and synthesized using a concise and efficient one-pot reaction protocol through 1,3-dipolar cycloaddition between 4-benzylidene-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one and chlorooximes. The synthesized derivatives were elucidated and characterized based on their spectroscopic data, including infrared spectrometry(IR), 1H NMR, 13C NMR, and elemental and mass spectral analysis. The synthesized compounds were evaluated for their antitumor inhibition potency against four human cancer cell lines, including human prostatic adenocarcinoma (PC3), human colorectal carcinoma(HCT116), human liver hepatocellular carcinoma(HepG2) and breast adenocarcinoma (MCF7). The outcomes were compared with the standard reference drug Doxorubicin. Among the synthesized chlorooximes, compounds 6d and 6e were the most active compounds on all cell lines. The spiro[pyrazole-4,5′-isoxazoline]-5-one derivatives 7a and 7c were active on the HepG2 liver cancer cell line. In comparison, compounds 7f and 7g were moderately active on the MCF7 cell line. The structure-activity relationship was explored for the synthesized compounds. Besides, in silico analysis of physicochemical, adsorption, distribution, metabolism, excretion and toxicity(ADMET) properties were done to determine the potential capacity of drug candidates. Molecular docking study onto the epidermal growth factor(EGF) tyrosine kinase receptor(3POZ) was done for the most active compounds to validate the reliability of in vitro anticancer screenings.
Similar content being viewed by others
References
Chauhan A., Sharma P., Kaushik N., Int. J. ChemTech Res., 2011, 3(1), 11
Brogden R. N., Drugs, 1986, 32(4), 60
Kasiotis K. M., Tzanetou E. N., Haroutounian S. A., Frontiers in Chemistry, 2014, 2, 78
Kumar V., Kaur K., Gupta G. K., Sharma A. K., European Journal of Medicinal Chemistry, 2013, 69, 735
Sondhi S. M., Jain S., Dinodia M., Shukla R., Raghubir R., Bioorganic & Medicinal Chemistry, 2007, 15(10), 3334
Palaska E., Aytemir M., Uzbay I. T., Erol D., European Journal of Medicinal Chemistry, 2001, 36(6), 539
Ma R., Zhu J., Liu J., Chen L., Shen X., Jiang H., Li J., Molecules, 2010, 15(5), 3593
Ribeiro C. J., Rodrigues C. M., Moreira R., Santos M. M., Pharmaceuticals, 2016, 9(2), 25
Khazir J., Singh P. P., Reddy D. M., Hyder I., Shafi S., Sawant S., Chashoo G., Mahajan A., Alam M., Saxena A., European Journal of Medicinal Chemistry, 2013, 63, 279
Das P., Boone S., Mitra D., Turner L., Tandon R., Raucher D., Hamme A. T., RSC Advances, 2020, 10(50), 30223
Karale B., Gadhave A., Indian Journal of Heterocyclic Chemistry, 2010, 19(4), 389
Duffy J. L., Bao J., Ondeyka D. L., Tyagarajan S., Shao P., Ye F., Katipally R., Finke P. E., Zang Y., Plotkin M. A., Patent WO 2011/146324, 2011
Zhang P.-Z., Li X.-L., Chen H., Li Y.-N., Wang R., Tetrahedron Letters, 2007, 48(44), 7813
Zhu S., Shi S., Gerritz S. W., Tetrahedron Letters, 2011, 52(31), 4001
Singh R., Goff D., Partridge J. J., Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating HCV infection, Patent US-2004266840-A1, 2006
Hassner A., Synthesis of Heterocycles via Cycloadditions I, Vol. 12, Springer, Verlag Berlin Heidelberg, 2008
Namboothiri I., Rastogi N., Springer, Berlin, Germany, 2008, 1
Sammelson R. E., Gurusinghe C. D., Kurth J. M., Olmstead M. M., Kurth M. J., Journal of Organic Chemistry, 2002, 67(3), 876
Yazdani H., Bazgir A., Synthesis, 2019, 51(07), 1669
Masumoto E., Shirouzu E., Kashige N., Okabe-Nakahara F., Miake F., Yamagata K., Maruoka H., Heterocycles, 2018, 96(7), 1289
Outahar F., Moumou M., Hannioui A., Rakib E. M., El Ammari L., Saadi M., Akssira M., Tetrahedron Letters, 2020, 61(42), 152409
Bora D., Kaushal A., Shankaraiah N., European Journal of Medicinal Chemistry, 2021, 113263
Madhuswapnaja K. J., Yennam S., Chavali M., Chemistry of Biologically Potent Natural Products and Synthetic Compounds, 2021, 155
Yu S., Qin D., Shangary S., Chen J., Wang G., Ding K., McEachern D., Qiu S., Nikolovska-Coleska Z., Miller R., Journal of Medicinal Chemistry, 2009, 52(24), 7970
Ewies E. F., El-Hussieny M., El-Sayed N. F., Ali M. M., Mahmoud A. E., Phosphorus, Sulfur, and Silicon and the Related Elements, 2016, 191 (7), 1000
Boulos L. S., Ewies E. F., Fahmy A. F., Mohram M. E., Phosphorus, Sulfur, and Silicon and the Related Elements, 2013, 188(6), 790
Ibrahim N. M., Yosef H. A., Ewies E. F., Mahran M. R., Ali M. M., Mahmoud A. E., Journal of the Brazilian Chemical Society, 2015, 26(6), 1086
Ewies E. F., El-Shehry M. F., Boulos L. S., Int. J. ChemTech Res., 2015, 7, 2506
Cohen J. B., A Class-book of Organic Chemistry, Vol.1, Macmillan and Co., Limited, London, 1920
Jiang K. M., Zhang J. Q., Jin Y., Lin J., Asian J. Org. Chem., 2017, 6, 1620
Franke A., Justus Liebigs Ann. Chem., 1978, 717
Azizian J., Jadidi K., Mehrdad M., Sarrafi Y., Synth. Commun., 2000, 30, 2309
Liu K.-C., Shelton B. R., Howe R. K., Journal of Organic Chemistry, 1980, 45(19), 3916
Mosmann T., J. Immunological Methods, 1983, 65(1/2), 55
Irmer D., Funk J., Blaukat A., Oncogene, 2007, 26(39), 5693
Berasain C., Avila M. A., Journal of Gastroenterology, 2014, 49(1), 9
Aertgeerts K., Skene R., Yano J., Sang B.-C., Zou H., Snell G., Jennings A., Iwamoto K., Habuka N., Hirokawa A., Journal of Biological Chemistry, 2011, 286(21), 18756
Risitano F., Grassi G., Foti F., Heterocycles, 2003, 60(4), 857
Ribeiro C. J., Amaral J. D., Rodrigues C. M., Moreira R., Santos M. M., Bioorganic & Medicinal chemistry, 2014, 22(1), 577
Phillips A. M. F., Pombeiro A. J., Kopylovich M. N., ChemCatChem, 2017, 9(2), 217
Wheeldon I., Minteer S. D., Banta S., Barton S. C., Atanassov P., Sigman M., Nature Chemistry, 2016, 8(4), 299
Zhao M. Y., Abraham M. H., Le J., Hersey A., Luscombe C. N., Beck G., Sherborne B., Cooper I., Pharm. Res., 2002, 19, 1446
Veber D. F., Johnson S. R., Cheng H.-Y., Smith B. R., Ward K. W., Kopple K. D., Journal of Medicinal Chemistry, 2002, 45(12), 2615
Acknowledgements
This work was supported by the Fund of National Research Centre, Egypt.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Conflicts of Interest
The authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Aljohani, G.F., El-Hag, F.A.A., Bekheit, M.S. et al. An Efficient One-pot Synthesis of Certain Stereoselective Spiro[pyrazole-4,5′-isoxazoline]-5-one Derivatives: In vitro Evaluation of Antitumor Activities, Molecular Docking and In silico ADME Predictions. Chem. Res. Chin. Univ. 38, 1073–1082 (2022). https://doi.org/10.1007/s40242-022-1408-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-022-1408-3